US Patent 11903994 Dosing regimens
Patent 11903994 was granted and assigned to Apellis Pharmaceuticals on February, 2024 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 7, 2016
0
Date of Patent
February 20, 2024
0
Patent Applicant
Patent Application Number
15766795
0
Patent Citations
•••
Patent Inventor Names
Cedric Francois
0
Pascal Deschatelets
0
Federico Grossi
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11903994 Dosing regimens
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
